Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy
2011 · Scientific Reports · 59 citations
https://doi.org/10.1038/srep00180
T
Takuma Hayashi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
254
Papers
2.4K
Citations
26
h-index
55
i10-index
Takuma Hayashi is an academic researcher from Kyoto Medical Center. The author has contributed to research in topics: Uterine Myomas and Treatments & Sarcoma Diagnosis and Treatment & Ovarian cancer diagnosis and treatment. The author has an h-index of 26, co-authored 216 publications.
ORCID: 0000-0002-7525-2048Papers by this author
worksLBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway
2011 · Leukemia · 55 citations
https://doi.org/10.1038/leu.2010.315
Correlation of anti-tumour drug resistance with epigenetic regulation
2020 · British Journal of Cancer · 22 citations
https://doi.org/10.1038/s41416-020-01183-y
Clinical pattern of primary systemic therapy and outcomes of estrogen receptor-positive, HER2-negative metastatic breast cancer: a review of a single institution
2017 · Breast Cancer Research and Treatment · 18 citations
https://doi.org/10.1007/s10549-017-4478-z
PL03.16 Spread Through Airspaces (STAS) and Prognosis in the Phase III JCOG0802/WJOG4607L Trial of Segmentectomy vs Lobectomy in NSCLC
2025 · Journal of Thoracic Oncology · 1 citations
https://doi.org/10.1016/j.jtho.2025.09.024
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat